• New $100M Program Aims to Improve Diversity in Clinical Trials
  • ALKS 4230-Keytruda Combo Found to Reduce Tumor Size, Halt Disease Progression
  • Study to Examine if Blood Test Can Detect Cancer Early in Low-Risk Women
  • ImmunoGen Teams Up With Huadong Medicine to Develop Mirvetuximab in China
  • CA125 Blood Test Useful in Diagnosing Ovarian Cancer in Routine Setting
  • Lynparza Combo Approved in EU as First-line Maintenance for Advanced Ovarian Cancer
  • First Patient Dosed in Phase 2 Study of Cancer Vaccine Combination in Ovarian Cancer
  • Zejula Approved in Europe as Maintenance Therapy for Advanced Ovarian Cancers
  • 3 Companies Join Forces to Test Personalized ‘Teaching’ Vaccine for Ovarian Cancer
  • Pilot Study Grants Available for Ovarian Cancer Research
  • FDA Places PC14586, for Cancers with Mutant Protein, on Fast Track
  • Phase 1 Trial of SL-172154 in Treating Advanced Ovarian Cancer Opens